. Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry. 1998 Mar 17;37(11):3602-11. PubMed.


Please login to recommend the paper.


  1. Information should accumulate on evidence in vivo and in vitro study on amyloid fibril aggregation and formation. They must contribute understanding for the basic etiology of the pathology of AD.

  2. Please see the following comments related to this article: Alzheimer's disease and amyloid beta protein Koudinov AR et al Science online,> Published 25 June 2002 [ Full Text ] Alzheimer’s anti-amyloid vaccination and statins: two approaches, one dogma. The time for change. Koudinov and Koudinova BMJ 20 March 2002 [ Full Text ] Dangers of the amyloid-beta vaccination. Smith MA et al. Acta Neuropathol (Berl) 2002 Jul;104(1):110 [ PubMed ] Call for Elan to publish Alzheimer's trial details Bishop et al. Nature. 416(6882): 677, 2002 Apr 18. [ PubMed ]


    . Dangers of the amyloid-beta vaccination. Acta Neuropathol. 2002 Jul;104(1):110. PubMed.

    . Call for Elan to publish Alzheimer's trial details. Nature. 2002 Apr 18;416(6882):677. PubMed.

Make a Comment

To make a comment you must login or register.

This paper appears in the following:


  1. SfN: Amyloid Oligomers—Not So Elusive, After All? Part 1